| Entry |
|
|---|
| Name |
Lumiracoxib (USAN/INN) |
|---|
| Formula |
C15H13ClFNO2
|
|---|
| Exact mass |
293.0619
|
|---|
| Mol weight |
293.72
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01922 Selective COX2 inhibitor
DG01907 Anti-inflammatory drug, coxibs
|
|---|
| Remark |
|
|---|
| Efficacy |
Anti-inflammatory, COX-2 inhibitor |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01AH Coxibs
M01AH06 Lumiracoxib
D03714 Lumiracoxib (USAN/INN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01922 Selective COX2 inhibitor
DG01907 Anti-inflammatory drug, coxibs
D03714 Lumiracoxib
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Prostaglandin synthase
PTGS2 (COX2)
D03714 Lumiracoxib (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 20
1 C8y C 35.8735 -17.2402
2 C8x C 35.8735 -18.6415
3 C8y C 34.6824 -19.3422
4 C8y C 33.4212 -18.6415
5 C8x C 33.4212 -17.2402
6 C8x C 34.6824 -16.5395
7 N1b N 32.2300 -19.3422
8 C8y C 31.0389 -18.6415
9 C8y C 29.8477 -19.3422
10 C8x C 28.5865 -18.6415
11 C8x C 28.5865 -17.2402
12 C8x C 29.7777 -16.5395
13 C8y C 31.0389 -17.2402
14 X F 29.8477 -20.7436
15 X Cl 32.2300 -16.5395
16 C1a C 37.0900 -16.5444
17 C1b C 34.6824 -20.7422
18 C6a C 35.8611 -21.4224
19 O6a O 35.8611 -22.8224
20 O6a O 37.0585 -20.7307
BOND 21
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 2
10 9 10 1
11 10 11 2
12 11 12 1
13 12 13 2
14 8 13 1
15 9 14 1
16 13 15 1
17 1 16 1
18 3 17 1
19 17 18 1
20 18 19 1
21 18 20 2
|
|---|
